Mroczkowski B - Search Results

1

Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes.

Krakowski ML, Kritzik MR, Jones EM, Krahl T, Lee J, Arnush M, Gu D, Mroczkowski B, Sarvetnick N. Krakowski ML, et al. Among authors: mroczkowski b. J Endocrinol. 1999 Aug;162(2):167-75. doi: 10.1677/joe.0.1620167. J Endocrinol. 1999. PMID: 10425454

2

Growth factors in the regenerating pancreas of gamma-interferon transgenic mice.

Arnush M, Gu D, Baugh C, Sawyer SP, Mroczkowski B, Krahl T, Sarvetnick N. Arnush M, et al. Among authors: mroczkowski b. Lab Invest. 1996 Jun;74(6):985-90. Lab Invest. 1996. PMID: 8667616

3

Identification of biologically active epidermal growth factor precursor in human fluids and secretions.

Mroczkowski B, Reich M. Mroczkowski B, et al. Endocrinology. 1993 Jan;132(1):417-25. doi: 10.1210/endo.132.1.8419140. Endocrinology. 1993. PMID: 8419140

4

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.

Christensen JG, Zou HY, Arango ME, Li Q, Lee JH, McDonnell SR, Yamazaki S, Alton GR, Mroczkowski B, Los G. Christensen JG, et al. Among authors: mroczkowski b. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3314-22. doi: 10.1158/1535-7163.MCT-07-0365. Mol Cancer Ther. 2007. PMID: 18089725

5

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.

Zou HY, Li Q, Lee JH, Arango ME, McDonnell SR, Yamazaki S, Koudriakova TB, Alton G, Cui JJ, Kung PP, Nambu MD, Los G, Bender SL, Mroczkowski B, Christensen JG. Zou HY, et al. Among authors: mroczkowski b. Cancer Res. 2007 May 1;67(9):4408-17. doi: 10.1158/0008-5472.CAN-06-4443. Cancer Res. 2007. PMID: 17483355

6

Expression of human epidermal growth factor precursor cDNA in transfected mouse NIH 3T3 cells.

Mroczkowski B, Reich M, Whittaker J, Bell GI, Cohen S. Mroczkowski B, et al. Proc Natl Acad Sci U S A. 1988 Jan;85(1):126-30. doi: 10.1073/pnas.85.1.126. Proc Natl Acad Sci U S A. 1988. PMID: 3257563 Free PMC article.

7

Expression of epidermal growth factor precursor cDNA in animal cells.

Mroczkowski B. Mroczkowski B. Methods Enzymol. 1991;198:175-85. doi: 10.1016/0076-6879(91)98018-2. Methods Enzymol. 1991. PMID: 1649948

8

Epidermal growth factor.

Mroczkowski B, Carpenter G. Mroczkowski B, et al. Prog Clin Biol Res. 1988;262:207-16. Prog Clin Biol Res. 1988. PMID: 3259699 No abstract available.

9

Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity.

Mroczkowski B, Reich M, Chen K, Bell GI, Cohen S. Mroczkowski B, et al. Mol Cell Biol. 1989 Jul;9(7):2771-8. doi: 10.1128/mcb.9.7.2771-2778.1989. Mol Cell Biol. 1989. PMID: 2789334 Free PMC article.

10

Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis.

Parast CV, Mroczkowski B, Pinko C, Misialek S, Khambatta G, Appelt K. Parast CV, et al. Among authors: mroczkowski b. Biochemistry. 1998 Nov 24;37(47):16788-801. doi: 10.1021/bi981291f. Biochemistry. 1998. PMID: 9843450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters